4z3k
From Proteopedia
(Difference between revisions)
m (Protected "4z3k" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | ''' | + | ==Human sepiapterin reductase in complex with the cofactor NADP+ and the trypthophan metabolite xanthurenic acid== |
- | + | <StructureSection load='4z3k' size='340' side='right' caption='[[4z3k]], [[Resolution|resolution]] 2.35Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[4z3k]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4Z3K OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4Z3K FirstGlance]. <br> | |
- | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=4KL:XANTHURIC+ACID'>4KL</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NAP:NADP+NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NAP</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | |
- | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4xwy|4xwy]]</td></tr> | |
- | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Sepiapterin_reductase_(L-erythro-7,8-dihydrobiopterin_forming) Sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.1.1.153 1.1.1.153] </span></td></tr> | |
- | [[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4z3k FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4z3k OCA], [http://pdbe.org/4z3k PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4z3k RCSB], [http://www.ebi.ac.uk/pdbsum/4z3k PDBsum]</span></td></tr> |
+ | </table> | ||
+ | == Disease == | ||
+ | [[http://www.uniprot.org/uniprot/SPRE_HUMAN SPRE_HUMAN]] Defects in SPR are the cause of dystonia DOPA-responsive due to sepiapterin reductase deficiency (DRDSPRD) [MIM:[http://omim.org/entry/612716 612716]]. In the majority of cases, patients manifest progressive psychomotor retardation, dystonia and spasticity. Cognitive anomalies are also often present. The disease is due to severe dopamine and serotonin deficiencies in the central nervous system caused by a defect in BH4 synthesis. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures.<ref>PMID:11443547</ref> <ref>PMID:16650784</ref> <ref>PMID:17159114</ref> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/SPRE_HUMAN SPRE_HUMAN]] Catalyzes the final one or two reductions in tetra-hydrobiopterin biosynthesis to form 5,6,7,8-tetrahydrobiopterin. | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
[[Category: Johnsson, K]] | [[Category: Johnsson, K]] | ||
+ | [[Category: Inhibitor]] | ||
+ | [[Category: Oxidoreductase]] | ||
+ | [[Category: Sepiapterin-reductase]] | ||
+ | [[Category: Tryptophan-metabolite]] | ||
+ | [[Category: Xanthurenic acid]] |
Revision as of 18:57, 1 December 2015
Human sepiapterin reductase in complex with the cofactor NADP+ and the trypthophan metabolite xanthurenic acid
|